Katelyn A Bustin

5PUBLICATIONS
26CO-AUTHORS
Major global burdens of diseaseProteomics and intermolecular interactions (excl. medical proteomics)Medical infection agents (incl. prions)Proteins and peptidesBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 15, 2025
Hydralazine inhibits cysteamine dioxygenase to treat preeclampsia and senesce glioblastoma.

Kyosuke Shishikura, Jiasong Li, Yiming Chen

|Jul 23, 2024
Activity-Based Protein Profiling of RHBDL4 Reveals Proteolysis of the Enzyme and a Distinct Inhibitor Profile.

Cassondra C Davies, Ren-Ming Hu, Paul J Kamitsuka

|Nov 17, 2022
Enterococci enhance Clostridioides difficile pathogenesis.

Alexander B Smith, Matthew L Jenior, Orlaith Keenan

|Mar 02, 2022
Discovery of Potent and Selective Inhibitors against Protein-Derived Electrophilic Cofactors.

Xie Wang, Zongtao Lin, Katelyn A Bustin

|Sep 29, 2021
Activity-Based Hydrazine Probes for Protein Profiling of Electrophilic Functionality in Therapeutic Targets.

Zongtao Lin, Xie Wang, Katelyn A Bustin

Pageof 1